Improved Synthesis of the Antitubercular Agent SQ109
We present here an improved procedure for the preparation of the promising antitubercular drug SQ109 that is currently in phase Ib/III of clinical trials against Mycobacterium tuberculosis. We investigated and tested the literature synthetic procedure that enables the development of structure–activi...
Main Authors: | Marianna Stampolaki, Antonios Kolocouris |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2021-12-01
|
Series: | SynOpen |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-1655-5867 |
Similar Items
-
Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450
by: Sergey Bukhdruker, et al.
Published: (2020-10-01) -
EFFICIENCY AND SAFETY OF CHEMOTHERAPY REGIMEN WITH SQ109 IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: S. E. Borisov, et al.
Published: (2018-04-01) -
MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature
by: Mohd. Imran, et al.
Published: (2022-11-01) -
In Vivo Efficacy of SQ109 against <i>Leishmania donovani</i>, <i>Trypanosoma</i> spp. and <i>Toxoplasma gondii</i> and In Vitro Activity of SQ109 Metabolites
by: Kyung-Hwa Baek, et al.
Published: (2022-03-01) -
СОЛНЕЧНО-СУТОЧНЫЕ ГЕОМАГНИТНЫЕ ВАРИАЦИИ: СЕЗОННЫЕ И ДОЛГОВРЕМЕННЫЕ ИЗМЕНЕНИЯ SqY, SqZ НА ОБСЕРВАТОРИИ AIA
by: O.I. Maksimenko, et al.
Published: (2018-06-01)